跳至主要内容
临床试验/NCT04743635
NCT04743635已完成不适用

CONtrolled Focal Fibrous Band Release Method Study

Revelle Aesthetics, Inc18 个研究点 分布在 2 个国家目标入组 74 人开始时间: 2021年1月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
18
主要终点
The Mean Change From Baseline to 3 Months in Cellulite Severity Scale (CSS) Score for Participants

研究概览

简要总结

Study to evaluate the safety and effectiveness of the Avéli medical device to reduce the appearance of cellulite.

详细描述

Multi-center, single-arm clinical study to evaluate the safety and effectiveness of the Avéli device in reducing the appearance of cellulite.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Moderate to severe cellulite

排除标准

  • Body Mass Index ≥30.0

结局指标

主要结局

The Mean Change From Baseline to 3 Months in Cellulite Severity Scale (CSS) Score for Participants

时间窗: 3 months

The CSS includes a 6-point (range of 0-5) and will be determined by 3 independent, blinded physician assessors of images obtained before and 3-months after treatment. CSS Scale TOTAL CSS SCORE: = (PART A + PART B) - 1 PART A- Number of evident depressions 0 None 1. Mild (≤4 depressions) 2. Moderate (5 to 9 depressions) 3. Severe (≥ 10 depressions) PART B - Average depth of depressions 0 None 1. Mild (1-2 mm) 2. Moderate (3-4 mm) 3. Severe (≥5 mm)

次要结局

  • The Mean Change From Baseline to 12 Months in Cellulite Severity Scale (CSS) Score for Participants(12 months)
  • Percentage of Participants With Improvement as Assessed Using Global Aesthetic Improvement Scale (GAIS) at 3 Months(3 months)
  • Percentage of Participants With Improvement as Assessed Using Global Aesthetic Improvement Scale (GAIS) at 12 Months(12 Months)
  • The Percentage of Patients Satisfied With Their Results at 3 Months(3 month)
  • The Number of Patients Satisfied With Their Results at 12 Months(12 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验

CONtrolled Focal Fibrous Band Release Method Study | 临床试验